Factors associated with PrEP‐era HIV seroconversion in a 4‐year U.S. national cohort of n = 6059 sexual and gender minority individuals who have sex with men, 2017−2022
Journal of the International AIDS Society · 2024-06 · 27 (6)
DOI: 10.1002/jia2.26312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the International AIDS Society, online erschienen am 25.06.2024. Verfasst von Christian Grov und 14 weiteren Autor:innen. Beteiligte Einrichtung: City University of New York (CUNY) Graduate School of Public Health and Health Policy, New York City, New York, USA. Hauptthemen laut MEDLINE: Sexual and Gender Minorities, Pre-Exposure Prophylaxis, Homosexuality, Male, HIV Seropositivity. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institute of Allergy and Infectious Diseases, NIAID NIH HHS.
Abstract (Originalsprache)
Introduction
Community‐based cohort studies of HIV seroconversion can identify important avenues for enhancing HIV prevention efforts in the era of pre‐exposure prophylaxis (PrEP). Within individuals, one can assess exposure and outcome variables repeatedly and with increased certainty regarding temporal ordering. This cohort study examined the association of several risk factors with subsequent HIV seroconversion.
Methods
We report data from a 4‐year study (2017−2022) of 6059 HIV seronegative sexual and gender minority individuals who have sex with men who had indications for‐, but were not using‐, PrEP at enrolment. Participants completed repeat exposure assessments and self‐collection of biospecimens for HIV testing. We examined the roles of race and ethnicity, socio‐economic status, methamphetamine use and PrEP uptake over the course of follow‐up in relation to HIV seroconversion.
Results
Over 4 years, 303 of the participants seroconverted across 18,421 person‐years (incidence rate = 1.64 [95% CI: 1.59−1.70] per 100 person‐years). In multivariable discrete‐time survival analysis, factors independently associated with elevated HIV seroconversion risk included being Black/African American (adjusted risk ratio [aRR]: 2.44, 1.79−3.28), Hispanic/Latinx (1.53, 1.19−1.96), housing instability (1.58, 1.22−2.05) and past year methamphetamine use (3.82, 2.74−5.33). Conversely, time since study enrolment (24 vs. 12 months, 0.67, 0.51−0.87; 36 months, 0.60, 0.45−0.80; 48 months, 0.48, 0.35−0.66) and higher education (master's degree or higher vs. less than or equal to high school, 0.36, 0.17−0.66) were associated with reduced seroconversion risk. Compared to non‐PrEP users in the past 2 years without a current clinical indication, those who started PrEP but then discontinued had higher seroconversion risk, irrespective of clinical indication (3.23, 1.74−6.46) or lack thereof (4.30, 1.85−9.88). However, those who initiated PrEP in the past year (0.14, 0.04−0.39) or persistently used PrEP in the past 2 years (0.33, 0.14−0.74) had a lower risk of seroconversion. Of all HIV seroconversions observed during follow‐up assessments (12, 24, 36 and 48 months), methamphetamine was reported in the 12 months prior 128 (42.2%) times (overall).
Conclusions
Interventions that acknowledge race and ethnicity, economic variables such as education and housing instability, and methamphetamine use are critically needed. Not only are interventions to engage individuals in PrEP care needed, but those that retain them, and re‐engage those who may fall out of care are essential, given the exceptionally high risk of seroconversion in these groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- City University of New York (CUNY) Graduate School of Public Health and Health Policy, New York City, New York, USA.
- CUNY Institute for Implementation Science in Population Health, New York City, New York, USA.
- University of Florida, Gainesville, Florida, USA.
- University of Memphis, Memphis, Tennessee, USA.
- University of Massachusetts Boston, Boston, Massachusetts, USA.
- Florida International University, Miami, Florida, USA.
ORCID-Profile: Christian Grov, Pedro Carneiro, Viraj V Patel
Förderung
- NIH HHS
- National Institute of Allergy and Infectious Diseases
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Grov, C., Guo, Y., Westmoreland, D. A., D'Angelo, A. B., Mirzayi, C., Dearolf, M., Carneiro, P., Ray, M., Pantalone, D., Carrico, A. W., Patel, V. V., Golub, S. A., Hirshfield, S., Hoover, D. R., & Nash, D. (2024). Factors associated with PrEP‐era HIV seroconversion in a 4‐year U.S. national cohort of n = 6059 sexual and gender minority individuals who have sex with men, 2017−2022. Journal of the International AIDS Society, 27(6). https://doi.org/10.1002/jia2.26312
Vancouver
Grov C, Guo Y, Westmoreland DA, D'Angelo AB, Mirzayi C, Dearolf M, et al. Factors associated with PrEP‐era HIV seroconversion in a 4‐year U.S. national cohort of n = 6059 sexual and gender minority individuals who have sex with men, 2017−2022. Journal of the International AIDS Society. 2024;27(6). doi:10.1002/jia2.26312
BibTeX
@article{Grov2024,
author = {Grov, Christian and Guo, Yan and Westmoreland, Drew A and D'Angelo, Alexa B and Mirzayi, Chloe and Dearolf, Michelle and Carneiro, Pedro and Ray, Meredith and Pantalone, David and Carrico, Adam W and Patel, Viraj V and Golub, Sarit A and Hirshfield, Sabina and Hoover, Donald R and Nash, Denis},
title = {Factors associated with PrEP‐era HIV seroconversion in a 4‐year U.S. national cohort of n = 6059 sexual and gender minority individuals who have sex with men, 2017−2022},
journal = {Journal of the International AIDS Society},
year = {2024},
volume = {27},
number = {6},
doi = {10.1002/jia2.26312}
}
EUVIMED